ARG1 and neoplasm: To more directly test the role of Arg1 in tumor growth, Arg1fl/flLysM-Cre+ or littermate control mice were injected with B16 tumor; mice lacking Arg1 expression in myeloid cells showed significantly decreased tumor growth compared to control mice on both days 14 and 21 after tumor injection (Fig. 7j).